2024
Abstract 4139258: Aspirin vs Clopidogrel as a Monotherapy secondary prevention in Patients with Coronary Artery Disease: An updated Meta-AnalysisCirculation, Antiplatelet Therapy and Cardiovascular Diseases
Active, last published 2026
0
H-index
0
Citations
Abdelrahman has not officially claimed their profile. If you are Abdelrahman, claim it free.
Claim Your Profile
Pioneer
LOCKED
Pathfinder
LOCKED
Scholar
EARNED
Innovator
LOCKED
Inventor
LOCKED
Catalyst
LOCKED
01 · About the work
What I study
research summary for Abdelrahman Elshimy will appear here once their profile is updated.
02 · Reach
Publication output and reach
Abdelrahman's work has been cited 0 times across 2 active years. Bars show publications per year; the line shows cumulative citation totals across publications first appearing in each year.
06 · Where I am
Affiliations
CurrentlyAlexandria University, Egypt
Research themes (UN SDGs)
07 · Selected work
Recent publications
View all 7 works2025
Which antiplatelet is better after stents? A meta-analysis of aspirin vs clopidogrel in the maintenance phaseNaunyn-Schmiedeberg s Archives of Pharmacology, Antiplatelet Therapy and Cardiovascular Diseases
2025Open access4cites
Non-fasting versus fasting before percutaneous cardiac procedures: a systematic review and meta-analysis of randomized controlled trialsPerioperative Medicine, Cardiac, Anesthesia and Surgical Outcomes
2025
Serum Procalcitonin Level as a Predictor for Prognostic Outcomes in Traumatic Brain Injury Patients: A Systematic Review and Meta-analysis (S26.008)Neurology, Sepsis Diagnosis and Treatment
2025Open access
Diagnostic Accuracy of Sonazoid-Enhanced Ultrasonography for Detection of Liver MetastasisMedical Sciences, Ultrasound and Hyperthermia Applications
Are you Abdelrahman?
Claim it to verify your details, connect with industry partners, and explore Fractional Domain Expert opportunities through MARATTO™.
African researchers are full of potential that too often goes unrecognised. Your MARATTO™ profile gives your work the commercial pathway it deserves.
Claim Your Profile
No commitment required